Cargando…

Hormone suppression silencing GUCY2C is required for colorectal cancer

Detalles Bibliográficos
Autor principal:	Waldman, Scott A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565465/ http://dx.doi.org/10.1186/2050-6511-16-S1-A31

Ejemplares similares

Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity
por: Pattison, Amanda M., et al.
Publicado: (2020)

GUCY2C at the intersection of obesity and colorectal cancer
por: Waldman, Scott A, et al.
Publicado: (2013)

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
por: Marszalowicz, Glen P., et al.
Publicado: (2014)

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
por: Magee, Michael S., et al.
Publicado: (2016)

APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis
por: Blomain, Erik S., et al.
Publicado: (2020)

Functional evaluation of GUCY1A3 mutations associated with myocardial infarction risk
por: Wobst, Jana, et al.
Publicado: (2015)

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
por: Cheslow, Lara, et al.
Publicado: (2023)

GUCY2C-targeted chimeric antigen receptor expressing T cells extend survival in a therapeutic mouse model of metastatic colorectal cancer
por: Magee, Michael S, et al.
Publicado: (2013)

Intestinal neuropod cell GUCY2C regulates visceral pain
por: Barton, Joshua R., et al.
Publicado: (2023)

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer
por: Rappaport, Jeffrey A., et al.
Publicado: (2021)

GUCY2C maintains intestinal LGR5(+) stem cells by opposing ER stress
por: Kraft, Crystal L., et al.
Publicado: (2017)

A Phase I study of AD5-GUCY2C-PADRE in stage I and II colon cancer patients
por: Snook, Adam, et al.
Publicado: (2015)

Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
por: Rampuria, Pragya, et al.
Publicado: (2023)

GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity
por: Lin, Jieru Egeria, et al.
Publicado: (2012)

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
por: Snook, Adam E., et al.
Publicado: (2019)

Congenital secretory diarrhoea caused by activating germline mutations in GUCY2C
por: Müller, Thomas, et al.
Publicado: (2016)

Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
por: von Volkmann, Hilde L., et al.
Publicado: (2017)

Overview of genetic markers for hereditary colorectal cancer
por: Scott, Rodney J
Publicado: (2012)

NKG2A silencing in effector cells to improve effectivity of cell based therapeutics
por: Figueiredo, C, et al.
Publicado: (2009)

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
por: Flickinger Jr, John C, et al.
Publicado: (2020)

Colorectal cancer screening in the elderly
por: Mastromarino, R, et al.
Publicado: (2013)

A Potential Treatment of Congenital Sodium Diarrhea in Patients With Activating GUCY2C Mutations
por: van Vugt, Anke H.M., et al.
Publicado: (2021)

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
por: Bar, Julia K, et al.
Publicado: (2012)

Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients
por: Li, Xin, et al.
Publicado: (2021)

The role of surgery for colorectal cancer in octogenarians
por: Basili, G, et al.
Publicado: (2009)

Management of colorectal cancer follow-up in elderly patients
por: Puleo, S, et al.
Publicado: (2010)

Our experience in surgery for colorectal cancer in elderly patients
por: Mosca, F, et al.
Publicado: (2010)

Is total colectomy for colorectal cancer contraindicated in elderly patients?
por: Grassia, S, et al.
Publicado: (2011)

Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C
por: Mishra, Vishwas, et al.
Publicado: (2021)

Analysis of factors influencing the results of colorectal cancer surgery in the elderly
por: Saracco, M, et al.
Publicado: (2013)

Angiogenesis in breast cancer: establishing a link between angiogenesis and hormone regulation
por: Soares, R, et al.
Publicado: (2000)

Familial risk and diagnosis of colorectal cancer in young individuals
por: Elsakov, Pavel
Publicado: (2015)

Role of microRNAs in the pathophysiology of sporadic colorectal cancer
por: Yong, Fung Lin, et al.
Publicado: (2012)

Relation of hormones in ductal lavage fluid to age, tamoxifen treatment, and breast cancer risk
por: Chatterton, RT, et al.
Publicado: (2009)

Time required for PaO(2) equilibration during mechanical ventilation with changes in FiO(2)
por: Cakar, N, et al.
Publicado: (1998)

Reference ranges for TSH and thyroid hormones
por: Lewandowski, Krzysztof
Publicado: (2015)

Thyroid hormones – obesity and metabolic syndrome
por: Bandurska-Stankiewicz, Elżbieta
Publicado: (2013)

Thyroid hormones and male reproductive system
por: Kula, Krzysztof
Publicado: (2013)

Interactions of metabolic syndrome and thyroid hormones
por: Brabant, Georg
Publicado: (2013)

Colorectal cancer surgery in the elderly: oncologic results from our experience
por: Selvaggi, F, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pu236ruvssj6comlrp4o2c5n51